Table of Contents 1 Study Coverage 1.1 RNA-based Biopharmaceuticals Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global RNA-based Biopharmaceuticals Market Size Growth Rate by Product 1.4.2 Therapeutics 1.4.3 Vaccines 1.5 Market by End User 1.5.1 Global RNA-based Biopharmaceuticals Market Size Growth Rate by End User 1.5.2 Cancer 1.5.3 Diabetes 1.5.4 Tuberculosis 1.5.5 Cardiovascular Diseases 1.5.6 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global RNA-based Biopharmaceuticals Market Size 2.1.1 Global RNA-based Biopharmaceuticals Revenue 2014-2025 2.1.2 Global RNA-based Biopharmaceuticals Sales 2014-2025 2.2 RNA-based Biopharmaceuticals Growth Rate by Regions 2.2.1 Global RNA-based Biopharmaceuticals Sales by Regions 2.2.2 Global RNA-based Biopharmaceuticals Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 RNA-based Biopharmaceuticals Sales by Manufacturers 3.1.1 RNA-based Biopharmaceuticals Sales by Manufacturers 3.1.2 RNA-based Biopharmaceuticals Sales Market Share by Manufacturers 3.1.3 Global RNA-based Biopharmaceuticals Market Concentration Ratio (CR5 and HHI) 3.2 RNA-based Biopharmaceuticals Revenue by Manufacturers 3.2.1 RNA-based Biopharmaceuticals Revenue by Manufacturers (2014-2019) 3.2.2 RNA-based Biopharmaceuticals Revenue Share by Manufacturers (2014-2019) 3.3 RNA-based Biopharmaceuticals Price by Manufacturers 3.4 RNA-based Biopharmaceuticals Manufacturing Base Distribution, Product Types 3.4.1 RNA-based Biopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers RNA-based Biopharmaceuticals Product Type 3.4.3 Date of International Manufacturers Enter into RNA-based Biopharmaceuticals Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global RNA-based Biopharmaceuticals Sales by Product 4.2 Global RNA-based Biopharmaceuticals Revenue by Product 4.3 RNA-based Biopharmaceuticals Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global RNA-based Biopharmaceuticals Breakdown Data by End User 6 North America 6.1 North America RNA-based Biopharmaceuticals by Countries 6.1.1 North America RNA-based Biopharmaceuticals Sales by Countries 6.1.2 North America RNA-based Biopharmaceuticals Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America RNA-based Biopharmaceuticals by Product 6.3 North America RNA-based Biopharmaceuticals by End User 7 Europe 7.1 Europe RNA-based Biopharmaceuticals by Countries 7.1.1 Europe RNA-based Biopharmaceuticals Sales by Countries 7.1.2 Europe RNA-based Biopharmaceuticals Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe RNA-based Biopharmaceuticals by Product 7.3 Europe RNA-based Biopharmaceuticals by End User 8 Asia Pacific 8.1 Asia Pacific RNA-based Biopharmaceuticals by Countries 8.1.1 Asia Pacific RNA-based Biopharmaceuticals Sales by Countries 8.1.2 Asia Pacific RNA-based Biopharmaceuticals Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific RNA-based Biopharmaceuticals by Product 8.3 Asia Pacific RNA-based Biopharmaceuticals by End User 9 Central & South America 9.1 Central & South America RNA-based Biopharmaceuticals by Countries 9.1.1 Central & South America RNA-based Biopharmaceuticals Sales by Countries 9.1.2 Central & South America RNA-based Biopharmaceuticals Revenue by Countries 9.1.3 Brazil 9.2 Central & South America RNA-based Biopharmaceuticals by Product 9.3 Central & South America RNA-based Biopharmaceuticals by End User 10 Middle East and Africa 10.1 Middle East and Africa RNA-based Biopharmaceuticals by Countries 10.1.1 Middle East and Africa RNA-based Biopharmaceuticals Sales by Countries 10.1.2 Middle East and Africa RNA-based Biopharmaceuticals Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa RNA-based Biopharmaceuticals by Product 10.3 Middle East and Africa RNA-based Biopharmaceuticals by End User 11 Company Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Company Business Overview 11.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Pfizer RNA-based Biopharmaceuticals Products Offered 11.1.5 Pfizer Recent Development 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Company Business Overview 11.2.3 Roche RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Roche RNA-based Biopharmaceuticals Products Offered 11.2.5 Roche Recent Development 11.3 Sanofi-Aventis 11.3.1 Sanofi-Aventis Company Details 11.3.2 Company Business Overview 11.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Products Offered 11.3.5 Sanofi-Aventis Recent Development 11.4 Abbott Laboratories 11.4.1 Abbott Laboratories Company Details 11.4.2 Company Business Overview 11.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Products Offered 11.4.5 Abbott Laboratories Recent Development 11.5 Arrowhead Pharmaceuticals 11.5.1 Arrowhead Pharmaceuticals Company Details 11.5.2 Company Business Overview 11.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Products Offered 11.5.5 Arrowhead Pharmaceuticals Recent Development 11.6 Benitec Biopharma 11.6.1 Benitec Biopharma Company Details 11.6.2 Company Business Overview 11.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Products Offered 11.6.5 Benitec Biopharma Recent Development 11.7 Calimmune Inc 11.7.1 Calimmune Inc Company Details 11.7.2 Company Business Overview 11.7.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Calimmune Inc RNA-based Biopharmaceuticals Products Offered 11.7.5 Calimmune Inc Recent Development 11.8 Dicerna 11.8.1 Dicerna Company Details 11.8.2 Company Business Overview 11.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Dicerna RNA-based Biopharmaceuticals Products Offered 11.8.5 Dicerna Recent Development 11.9 Gradalis 11.9.1 Gradalis Company Details 11.9.2 Company Business Overview 11.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Gradalis RNA-based Biopharmaceuticals Products Offered 11.9.5 Gradalis Recent Development 11.10 Quark 11.10.1 Quark Company Details 11.10.2 Company Business Overview 11.10.3 Quark RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Quark RNA-based Biopharmaceuticals Products Offered 11.10.5 Quark Recent Development 11.11 RXi 11.12 Senesco 11.13 Silence Therapeutics 11.14 Silenseed 11.15 Tekmira 11.16 Alnylam Pharmaceuticals 12 Future Forecast 12.1 RNA-based Biopharmaceuticals Market Forecast by Regions 12.1.1 Global RNA-based Biopharmaceuticals Sales Forecast by Regions 2019-2025 12.1.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Regions 2019-2025 12.2 RNA-based Biopharmaceuticals Market Forecast by Product 12.2.1 Global RNA-based Biopharmaceuticals Sales Forecast by Product 2019-2025 12.2.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Product 2019-2025 12.3 RNA-based Biopharmaceuticals Market Forecast by End User 12.4 North America RNA-based Biopharmaceuticals Forecast 12.5 Europe RNA-based Biopharmaceuticals Forecast 12.6 Asia Pacific RNA-based Biopharmaceuticals Forecast 12.7 Central & South America RNA-based Biopharmaceuticals Forecast 12.8 Middle East and Africa RNA-based Biopharmaceuticals Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 RNA-based Biopharmaceuticals Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure RNA-based Biopharmaceuticals Product Picture Table RNA-based Biopharmaceuticals Market Segments Table Key Manufacturers RNA-based Biopharmaceuticals Covered Table Global RNA-based Biopharmaceuticals Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global RNA-based Biopharmaceuticals Sales Market Share by Product 2014-2025 Figure Therapeutics Product Picture Table Major Manufacturers of Therapeutics Figure Vaccines Product Picture Table Major Manufacturers of Vaccines Table Global RNA-based Biopharmaceuticals Market Size Growth Rate by End User 2019-2025 (K Units) Figure Cancer Figure Diabetes Figure Tuberculosis Figure Cardiovascular Diseases Figure Others Figure RNA-based Biopharmaceuticals Report Years Considered Figure Global RNA-based Biopharmaceuticals Market Size 2014-2025 (Million US$) Figure Global RNA-based Biopharmaceuticals Sales 2014-2025 (K Units) Table Global RNA-based Biopharmaceuticals Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global RNA-based Biopharmaceuticals Sales by Regions 2014-2019 (K Units) Table Global RNA-based Biopharmaceuticals Sales Market Share by Regions 2014-2019 Figure Global RNA-based Biopharmaceuticals Sales Market Share by Regions 2014-2019 Figure 2018 Global RNA-based Biopharmaceuticals Sales Market Share by Regions Table Global RNA-based Biopharmaceuticals Revenue by Regions 2014-2019 (Million US$) Table Global RNA-based Biopharmaceuticals Revenue Market Share by Regions 2014-2019 Figure Global RNA-based Biopharmaceuticals Revenue Market Share by Regions 2014-2019 Figure 2018 Global RNA-based Biopharmaceuticals Revenue Market Share by Regions Table Global RNA-based Biopharmaceuticals Sales by Manufacturers (2014-2019) (K Units) Table Global RNA-based Biopharmaceuticals Sales Share by Manufacturers (2014-2019) Figure Global RNA-based Biopharmaceuticals Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table RNA-based Biopharmaceuticals Revenue by Manufacturers (2014-2019) (Million USD) Table RNA-based Biopharmaceuticals Revenue Share by Manufacturers (2014-2019) Figure RNA-based Biopharmaceuticals Value Share by Manufacturers in 2018 Table Key Manufacturers RNA-based Biopharmaceuticals Price (2014-2019) (USD/Unit) Table RNA-based Biopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers RNA-based Biopharmaceuticals Product Type Table Date of International Manufacturers Enter into RNA-based Biopharmaceuticals Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global RNA-based Biopharmaceuticals Sales by Product (2014-2019) (K Units) Table Global RNA-based Biopharmaceuticals Sales Share by Product (2014-2019) Figure Global RNA-based Biopharmaceuticals Sales Market Share by Product (2014-2019) Figure Global RNA-based Biopharmaceuticals Sales Market Share by Product in 2018 Table Global RNA-based Biopharmaceuticals Revenue by Product (2014-2019) (Million US$) Table Global RNA-based Biopharmaceuticals Revenue Share by Product (2014-2019) Figure Global RNA-based Biopharmaceuticals Revenue Market Share by Product (2014-2019) Figure Global RNA-based Biopharmaceuticals Revenue Market Share by Product in 2018 Table RNA-based Biopharmaceuticals Price by Product 2014-2019 (USD/Unit) Table Global RNA-based Biopharmaceuticals Sales by End User (2014-2019) (K Units) Table Global RNA-based Biopharmaceuticals Sales Share by End User (2014-2019) Figure Global Sales RNA-based Biopharmaceuticals Market Share by End User (2014-2019) Figure Global Sales RNA-based Biopharmaceuticals Market Share by End User in 2018 Figure North America RNA-based Biopharmaceuticals Sales Growth Rate 2014-2019 (K Units) Figure North America RNA-based Biopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$) Table North America RNA-based Biopharmaceuticals Sales by Countries (2014-2019) (K Units) Table North America RNA-based Biopharmaceuticals Sales Market Share by Countries (2014-2019) Figure 2018 North America RNA-based Biopharmaceuticals Sales Market Share by Countries Table North America RNA-based Biopharmaceuticals Revenue by Countries (2014-2019) (Million US$) Table North America RNA-based Biopharmaceuticals Revenue Market Share by Countries (2014-2019) Figure 2018 North America RNA-based Biopharmaceuticals Revenue Market Share by Countries Figure United States RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure United States RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (K Units) Figure Canada RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Canada RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Mexico RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Table North America RNA-based Biopharmaceuticals Sales by Product (2014-2019) (K Units) Table North America RNA-based Biopharmaceuticals Sales Market Share by Product (2014-2019) Figure 2018 North America RNA-based Biopharmaceuticals Market Share by Product Table North America RNA-based Biopharmaceuticals Sales by End User (2014-2019) (K Units) Table North America RNA-based Biopharmaceuticals Sales Market Share by End User (2014-2019) Figure 2018 North America RNA-based Biopharmaceuticals Market Share by End User Figure Europe RNA-based Biopharmaceuticals Sales Growth Rate 2014-2019 (K Units) Figure Europe RNA-based Biopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$) Table Europe RNA-based Biopharmaceuticals Sales by Countries (2014-2019) (K Units) Table Europe RNA-based Biopharmaceuticals Sales Market Share by Countries (2014-2019) Figure 2018 Europe RNA-based Biopharmaceuticals Sales Market Share by Countries Table Europe RNA-based Biopharmaceuticals Revenue by Countries (2014-2019) (Million US$) Table Europe RNA-based Biopharmaceuticals Revenue Market Share by Countries (2014-2019) Figure 2018 Europe RNA-based Biopharmaceuticals Revenue Market Share by Countries Figure Germany RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Germany RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure France RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure France RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure UK RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure UK RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Italy RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Italy RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Russia RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Russia RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Table Europe RNA-based Biopharmaceuticals Sales by Product (2014-2019) (K Units) Table Europe RNA-based Biopharmaceuticals Sales Market Share by Product (2014-2019) Figure 2018 Europe RNA-based Biopharmaceuticals Market Share by Product Table Europe RNA-based Biopharmaceuticals Sales by End User (2014-2019) (K Units) Table Europe RNA-based Biopharmaceuticals Sales Market Share by End User (2014-2019) Figure 2018 Europe RNA-based Biopharmaceuticals Market Share by End User Figure Asia Pacific RNA-based Biopharmaceuticals Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific RNA-based Biopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific RNA-based Biopharmaceuticals Sales by Countries (2014-2019) (K Units) Table Asia Pacific RNA-based Biopharmaceuticals Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific RNA-based Biopharmaceuticals Sales Market Share by Countries Table Asia Pacific RNA-based Biopharmaceuticals Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific RNA-based Biopharmaceuticals Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific RNA-based Biopharmaceuticals Revenue Market Share by Countries Figure China RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure China RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Japan RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Japan RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Korea RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Korea RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure India RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure India RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Australia RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Australia RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Indonesia RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Malaysia RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Philippines RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Thailand RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Vietnam RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Singapore RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific RNA-based Biopharmaceuticals Sales by Product (2014-2019) (K Units) Table Asia Pacific RNA-based Biopharmaceuticals Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific RNA-based Biopharmaceuticals Market Share by Product Table Asia Pacific RNA-based Biopharmaceuticals Sales by End User (2014-2019) (K Units) Table Asia Pacific RNA-based Biopharmaceuticals Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific RNA-based Biopharmaceuticals Market Share by End User Figure Central & South America RNA-based Biopharmaceuticals Sales Growth Rate 2014-2019 (K Units) Figure Central & South America RNA-based Biopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America RNA-based Biopharmaceuticals Sales by Countries (2014-2019) (K Units) Table Central & South America RNA-based Biopharmaceuticals Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America RNA-based Biopharmaceuticals Sales Market Share by Countries Table Central & South America RNA-based Biopharmaceuticals Revenue by Countries (2014-2019) (Million US$) Table Central & South America RNA-based Biopharmaceuticals Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America RNA-based Biopharmaceuticals Revenue Market Share by Countries Figure Brazil RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Brazil RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Argentina RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America RNA-based Biopharmaceuticals Sales by Product (2014-2019) (K Units) Table Central & South America RNA-based Biopharmaceuticals Sales Market Share by Product (2014-2019) Figure 2018 Central & South America RNA-based Biopharmaceuticals Market Share by Product Table Central & South America RNA-based Biopharmaceuticals Sales by End User (2014-2019) (K Units) Table Central & South America RNA-based Biopharmaceuticals Sales Market Share by End User (2014-2019) Figure 2018 Central & South America RNA-based Biopharmaceuticals Market Share by End User Figure Middle East and Africa RNA-based Biopharmaceuticals Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa RNA-based Biopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa RNA-based Biopharmaceuticals Sales by Countries (2014-2019) (K Units) Table Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share by Countries Table Middle East and Africa RNA-based Biopharmaceuticals Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa RNA-based Biopharmaceuticals Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa RNA-based Biopharmaceuticals Revenue Market Share by Countries Figure GCC Countries RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Turkey RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure Egypt RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa RNA-based Biopharmaceuticals Sales Growth Rate (2014-2019) (K Units) Figure South Africa RNA-based Biopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa RNA-based Biopharmaceuticals Sales by Product (2014-2019) (K Units) Table Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa RNA-based Biopharmaceuticals Market Share by Product Table Middle East and Africa RNA-based Biopharmaceuticals Sales by End User (2014-2019) (K Units) Table Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa RNA-based Biopharmaceuticals Market Share by End User Table Pfizer Company Details Table Pfizer RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Recent Development Table Roche Company Details Table Roche RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Roche Recent Development Table Sanofi-Aventis Company Details Table Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Sanofi-Aventis Recent Development Table Abbott Laboratories Company Details Table Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Abbott Laboratories Recent Development Table Arrowhead Pharmaceuticals Company Details Table Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Arrowhead Pharmaceuticals Recent Development Table Benitec Biopharma Company Details Table Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Benitec Biopharma Recent Development Table Calimmune Inc Company Details Table Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Calimmune Inc Recent Development Table Dicerna Company Details Table Dicerna RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Dicerna Recent Development Table Gradalis Company Details Table Gradalis RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Gradalis Recent Development Table Quark Company Details Table Quark RNA-based Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Quark Recent Development Table RXi Company Details Table Senesco Company Details Table Silence Therapeutics Company Details Table Silenseed Company Details Table Tekmira Company Details Table Alnylam Pharmaceuticals Company Details Table Global RNA-based Biopharmaceuticals Sales Forecast by Regions 2019-2025 (K Units) Table Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Regions 2019-2025 Table Global RNA-based Biopharmaceuticals Revenue Forecast by Regions 2019-2025 (Million US$) Table Global RNA-based Biopharmaceuticals Revenue Market Share Forecast by Regions 2019-2025 Table Global RNA-based Biopharmaceuticals Sales Forecast by Product 2019-2025 (K Units) Table Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Product 2019-2025 Table Global RNA-based Biopharmaceuticals Revenue Forecast by Product 2019-2025 (Million US$) Table Global RNA-based Biopharmaceuticals Revenue Market Share Forecast by Product 2019-2025 Table Global RNA-based Biopharmaceuticals Sales Forecast by End User 2019-2025 (K Units) Table Global RNA-based Biopharmaceuticals Sales Market Share Forecast by End User 2019-2025 Figure North America RNA-based Biopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America RNA-based Biopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe RNA-based Biopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe RNA-based Biopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific RNA-based Biopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific RNA-based Biopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America RNA-based Biopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America RNA-based Biopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa RNA-based Biopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa RNA-based Biopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$) Table RNA-based Biopharmaceuticals Value Chain Table RNA-based Biopharmaceuticals Customers List Table RNA-based Biopharmaceuticals Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer Roche Sanofi-Aventis Abbott Laboratories Arrowhead Pharmaceuticals Benitec Biopharma Calimmune Inc Dicerna Gradalis Quark RXi Senesco Silence Therapeutics Silenseed Tekmira Alnylam Pharmaceuticals